Pictet Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$868M Buy
943,976
+63,470
+7% +$64.3M 0.92% 14
2025
Q4
$946M Buy
880,506
+190,126
+28% +$182M 0.92% 15
2025
Q3
$526M Sell
690,380
-25,141
-4% -$18.7M 0.51% 40
2025
Q2
$558M Buy
715,521
+18,907
+3% +$14.7M 0.57% 34
2025
Q1
$575M Buy
696,614
+34,244
+5% +$28.5M 0.64% 32
2024
Q4
$511M Buy
662,370
+40,778
+7% +$33.8M 0.55% 39
2024
Q3
$551M Buy
621,592
+6,691
+1% +$6.02M 0.61% 34
2024
Q2
$557M Sell
614,901
-50,372
-8% -$40.3M 0.64% 33
2024
Q1
$518M Buy
665,273
+23,774
+4% +$16.9M 0.56% 36
2023
Q4
$374M Buy
641,499
+9,604
+2% +$5.61M 0.41% 61
2023
Q3
$339M Buy
+631,895
New +$326M 0.42% 62

Other funds holding LLY

Pictet Asset Management's LLY Position: Q1 2026 in Review

Pictet Asset Management increased its Eli Lilly (LLY) stake by 7.2% in Q1 2026, buying an estimated $64.3M and bringing the position to 943,976 shares worth $868M. The position accounts for 0.92% of the portfolio, ranked #14.

Pictet Asset Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $946M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pictet Asset Management held 943,976 shares of Eli Lilly worth $868M as of Q1 2026.
  • Pictet Asset Management bought 63,470 Eli Lilly shares in Q1 2026, an estimated $64.3M.
  • Eli Lilly made up 0.92% of Pictet Asset Management's portfolio in Q1 2026, its #14 holding.
  • Pictet Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Eli Lilly position peaked at $946M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.